Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.
|Articles|December 21, 2007
DEA hits third Cardinal Health distribution center
The DEA has suspended the license from a third Cardinal Health distribution center located in Swedesboro, N.J.
Advertisement
The Drug Enforcement Administration has suspended the license to distribute controlled substances at Cardinal Health's Swedeboro, N.J., distribution center, according to the company. The N.J. facility was the third in less than a month to have its license suspended, following similar actions at distribution centers in Washington and Florida. In an open
Advertisement
Related to this article
AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026
2
FAQ: Scaling Pharmacy Services Through GLP-1 Care | NCPA 2026
3
Pharmacists Must Guide Peptide Talks Pending FDA Action | NCPA 2026
4
FDA Approves Brytly for OTC Eye Redness Relief
5